Alentis Therapeutics AG
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreThese trailblazers have scaled beyond expectations—becoming industry leaders, job creators, and global ambassadors of Swiss excellence. Their journeys reflect the power of vision, resilience, and innovation. Discover the startups that are transforming industries and inspiring the world shapers of tomorrow.
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreInnovative solutions for sustainable agriculture
Read moreYour expenses and company credit cards on autopilot
Read moreOnline tools to edit PDFs
Read moreAntibody-based NBEs
Read moreNext-generation engineered cytokines
Read moreEnabling nervous system rewiring
Read moreImmunotherapies for cancer
Read more